Tradestie Institutional Equity Comparison Engine
ABVE vs HLF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HLF Overall Edge
HLF Captures Institutional Edge (4โ0 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Herbalife Ltd. (HLF) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABVE trades at N/M Forward P/E with -23.2% operating margin (-45.0% YoY revenue) versus HLF at 5.3x Forward P/E and 9.8% operating margin (+6.0% YoY). In options structure, ABVE sits in UNCLASSIFIED (8th %ile IV; Dealer Gamma Walls on Pro) against HLF sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HLF
ABVE N/M vs HLF 5.3x Fwd P/E
Growth & Margin Winner
HLF
Op Margin -23.2% vs 9.8% ยท YoY -45.0% vs +6.0%
Momentum & Technical Winner
HLF
1Y -90.2% vs +68.9% ยท 52W Pos 0% vs 62%
Options & Structure Winner
HLF
UNCLASSIFIED (8th %ile IV) vs SURGE (8th %ile IV)
ABVE
NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap
$30.0M
1M Return
-79.18%
1Y Return
-90.17%
Forward P/E
N/M
Unified AI Score
39.8 / 100
SELL
Tech 40.0
Fund 47.0
Flow 57.0
Mom 40.0
HLF
NYSE
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$15.93
-0.19% 1D
Market Cap
$1.6B
1M Return
+9.11%
1Y Return
+68.93%
Forward P/E
5.3x
Unified AI Score
35.2 / 100
SELL
Tech 50.0
Fund 31.0
Flow 59.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVE -90.17%
HLF +68.93%
Spread: +120.57 pp (HLF Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVE TTM Op. Margin: -23.2%
HLF TTM Op. Margin: 9.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs HLF. Trailing 12-month operating profitability (ABVE -23.2% vs HLF 9.8%) and valuation multiples (ABVE N/M vs HLF 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVE | HLF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $30.0M | $1.6B | Larger Scale | HLF |
| Trailing P/E Ratio Valuation | N/M | 8.9x | Lower Multiple | HLF |
| Forward P/E Ratio Valuation | N/M | 5.3x | Lower Multiple | HLF |
| Revenue Growth (YoY) Growth | -45.0% | +6.0% | Higher Growth | HLF |
| Operating Margin (TTM) Profitability | -23.2% | 9.8% | Higher Margin | HLF |
| Net Profit Margin Profitability | -23.4% | 3.4% | Higher Margin | HLF |
| Return on Equity (ROE) Capital Efficiency | 0.0% | 0.0% | Higher ROE | Tie |
| 52-Week Range Position Momentum | 0% ($0โ$7) | 62% ($9โ$20) | Stronger Trend | HLF |
| Beta / 30D Volatility Risk Regime | 4.10ฮฒ ยท 310% Vol | 1.08ฮฒ ยท 48% Vol | Lower Realized Risk | HLF |
| Unified Institutional Score Composite Signal | 39.8 / 100 (SELL) | 35.2 / 100 (SELL) | Higher Composite | ABVE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVE vs HLF Buy Guide
ABVE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
HLF
SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVE nor HLF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.